HuGE Literature Finder
Records
1
-
3
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. The Lancet. Oncology 2016 Mar . Cristofanilli Massimo, Turner Nicholas C, Bondarenko Igor, Ro Jungsil, Im Seock-Ah, Masuda Norikazu, Colleoni Marco, DeMichele Angela, Loi Sherene, Verma Sunil, Iwata Hiroji, Harbeck Nadia, Zhang Ke, Theall Kathy Puyana, Jiang Yuqiu, Bartlett Cynthia Huang, Koehler Maria, Slamon Denn |
Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 2008 Feb 29 (2): 333-41. Driver Kristy E, Song Honglin, Lesueur Fabienne, Ahmed Shahana, Barbosa-Morais Nuno L, Tyrer Jonathan P, Ponder Bruce A J, Easton Douglas F, Pharoah Paul D P, Dunning Alison M, |
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast cancer research : BCR 2008 10 (3): R47. Azzato Elizabeth M, Driver Kristy E, Lesueur Fabienne, Shah Mitul, Greenberg David, Easton Douglas F, Teschendorff Andrew E, Caldas Carlos, Caporaso Neil E, Pharoah Paul D |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 24, 2022
- Content source: